Back to Authors

Gurish, Michael F.

https://orcid.org/0000-0002-7893-3156

Mayo Clinic

Brigham and Women's Hospital

Citations 1

Mast cells promote small bowel cancer in a tumor stage-specific and cytokine-dependent manner
Osman, Abu , Gurish, Michael F. , Dennis, Kristen L., Blatner, Nichole R., Pezeshki, Abdulmohammad , McNagny, Kelly M. , Cheroutre, Hilde , Gounari, Fotini , Khazaie, Khashayarsha , Saadalla, Abdulrahman M, McNagny, Kelly M , Khazaie, Khashayarsha , Saadalla, Abdulrahman , Gounari, Fotini

Proceedings of the National Academy of Sciences | February 2, 2018 | Volume: 115 | Issue: 7 | Pages: 1588-1592

10.1073/pnas.1716804115 Get It

Significance We show that distinct subsets of mast cells (MCs) expand with sequential oncogenic events in small bowel cancer. Mucosal mast cells (MMCs) previously detected early during Trichinella spiralis infection expand in adenomatous polyps in an IL-10–dependent manner. Connective tissue mast cells (CTMCs), earlier shown to expand during the resolution of inflammation following clearance of T. spiralis, are independent of IL-10 and associate with the transition of polyps to adenocarcinoma. IL-33 upregulates the CTMC lineage-specific protease murine mast cell protease 6 (mMCP6). Ablation of mMCP6 attenuates tumor growth. Thus, tissue sentinel cells respond to oncogenic events and cellular transformation in effect to help promote cancer. Delineating the types of MCs present at various stages of disease offers actionable cellular targets for therapeutic intervention in disease progression.